Literature DB >> 27389779

De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.

Esther R Berko1, Megan T Cho2, Christine Eng3, Yunru Shao3,4, David A Sweetser5, Jessica Waxler5, Nathaniel H Robin6, Fallon Brewer6, Sandra Donkervoort7, Payam Mohassel7, Carsten G Bönnemann7, Martin Bialer8, Christine Moore8, Lynne A Wolfe9,10, Cynthia J Tifft9,10, Yufeng Shen11, Kyle Retterer2, Francisca Millan2, Wendy K Chung1,12.   

Abstract

BACKGROUND: The causes of intellectual disability (ID) are diverse and de novo mutations are increasingly recognised to account for a significant proportion of ID. METHODS AND
RESULTS: In this study, we performed whole exome sequencing on a large cohort of patients with ID or neurodevelopmental delay and identified four novel de novo predicted deleterious missense variants in HECW2 in six probands with ID/developmental delay and hypotonia. Other common features include seizures, strabismus, nystagmus, cortical visual impairment and dysmorphic facial features. HECW2 is an ubiquitin ligase that stabilises p73, a crucial mediator of neurodevelopment and neurogenesis.
CONCLUSION: This study implicates pathogenic genetic variants in HECW2 as potential causes of neurodevelopmental disorders in humans. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  HECW2; de novo; intellectual disability; neurodevelopmental delay; whole exome sequencing

Mesh:

Substances:

Year:  2016        PMID: 27389779      PMCID: PMC5222737          DOI: 10.1136/jmedgenet-2016-103943

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  34 in total

1.  Cdh1-APC controls axonal growth and patterning in the mammalian brain.

Authors:  Yoshiyuki Konishi; Judith Stegmüller; Takahiko Matsuda; Shirin Bonni; Azad Bonni
Journal:  Science       Date:  2004-01-08       Impact factor: 47.728

2.  p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis.

Authors:  F Talos; A Abraham; A V Vaseva; L Holembowski; S E Tsirka; A Scheel; D Bode; M Dobbelstein; W Brück; U M Moll
Journal:  Cell Death Differ       Date:  2010-12       Impact factor: 15.828

Review 3.  The diverse genetic landscape of neurodevelopmental disorders.

Authors:  Wen F Hu; Maria H Chahrour; Christopher A Walsh
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

Review 4.  Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms.

Authors:  Anand K Srivastava; Charles E Schwartz
Journal:  Neurosci Biobehav Rev       Date:  2014-04-04       Impact factor: 8.989

5.  Genome sequencing identifies major causes of severe intellectual disability.

Authors:  Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

6.  Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons.

Authors:  C Gieffers; B H Peters; E R Kramer; C G Dotti; J M Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

7.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.

Authors:  Anita Rauch; Dagmar Wieczorek; Elisabeth Graf; Thomas Wieland; Sabine Endele; Thomas Schwarzmayr; Beate Albrecht; Deborah Bartholdi; Jasmin Beygo; Nataliya Di Donato; Andreas Dufke; Kirsten Cremer; Maja Hempel; Denise Horn; Juliane Hoyer; Pascal Joset; Albrecht Röpke; Ute Moog; Angelika Riess; Christian T Thiel; Andreas Tzschach; Antje Wiesener; Eva Wohlleber; Christiane Zweier; Arif B Ekici; Alexander M Zink; Andreas Rump; Christa Meisinger; Harald Grallert; Heinrich Sticht; Annette Schenck; Hartmut Engels; Gudrun Rappold; Evelin Schröck; Peter Wieacker; Olaf Riess; Thomas Meitinger; André Reis; Tim M Strom
Journal:  Lancet       Date:  2012-09-27       Impact factor: 79.321

8.  Genic intolerance to functional variation and the interpretation of personal genomes.

Authors:  Slavé Petrovski; Quanli Wang; Erin L Heinzen; Andrew S Allen; David B Goldstein
Journal:  PLoS Genet       Date:  2013-08-22       Impact factor: 5.917

9.  Clinical application of whole-exome sequencing across clinical indications.

Authors:  Kyle Retterer; Jane Juusola; Megan T Cho; Patrik Vitazka; Francisca Millan; Federica Gibellini; Annette Vertino-Bell; Nizar Smaoui; Julie Neidich; Kristin G Monaghan; Dianalee McKnight; Renkui Bai; Sharon Suchy; Bethany Friedman; Jackie Tahiliani; Daniel Pineda-Alvarez; Gabriele Richard; Tracy Brandt; Eden Haverfield; Wendy K Chung; Sherri Bale
Journal:  Genet Med       Date:  2015-12-03       Impact factor: 8.822

10.  A framework for the interpretation of de novo mutation in human disease.

Authors:  Kaitlin E Samocha; Elise B Robinson; Stephan J Sanders; Christine Stevens; Aniko Sabo; Lauren M McGrath; Jack A Kosmicki; Karola Rehnström; Swapan Mallick; Andrew Kirby; Dennis P Wall; Daniel G MacArthur; Stacey B Gabriel; Mark DePristo; Shaun M Purcell; Aarno Palotie; Eric Boerwinkle; Joseph D Buxbaum; Edwin H Cook; Richard A Gibbs; Gerard D Schellenberg; James S Sutcliffe; Bernie Devlin; Kathryn Roeder; Benjamin M Neale; Mark J Daly
Journal:  Nat Genet       Date:  2014-08-03       Impact factor: 38.330

View more
  17 in total

1.  A De Novo HECW2 Variant in a Patient with Acetazolamide-Responsive Episodic Ataxia.

Authors:  Leticia Maria Tedesco Silva; Sonali Sharma; Isabelle Schrauwen; Jason Margolesky; Kamil Detyniecki
Journal:  Cerebellum       Date:  2022-08-20       Impact factor: 3.648

2.  Dnmt3a knockout in excitatory neurons impairs postnatal synapse maturation and increases the repressive histone modification H3K27me3.

Authors:  Junhao Li; Antonio Pinto-Duarte; Mark Zander; Michael S Cuoco; Chi-Yu Lai; Julia Osteen; Linjing Fang; Chongyuan Luo; Jacinta D Lucero; Rosa Gomez-Castanon; Joseph R Nery; Isai Silva-Garcia; Yan Pang; Terrence J Sejnowski; Susan B Powell; Joseph R Ecker; Eran A Mukamel; M Margarita Behrens
Journal:  Elife       Date:  2022-05-23       Impact factor: 8.713

3.  De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies.

Authors:  Sathiya N Manivannan; Jolien Roovers; Noor Smal; Candace T Myers; Dilsad Turkdogan; Filip Roelens; Oguz Kanca; Hyung-Lok Chung; Tasja Scholz; Katharina Hermann; Tatjana Bierhals; Hande S Caglayan; Hannah Stamberger; Heather Mefford; Peter de Jonghe; Shinya Yamamoto; Sarah Weckhuysen; Hugo J Bellen
Journal:  Brain       Date:  2022-06-03       Impact factor: 15.255

4.  Loss of the neurodevelopmental gene Zswim6 alters striatal morphology and motor regulation.

Authors:  David J Tischfield; Dave K Saraswat; Andrew Furash; Stephen C Fowler; Marc V Fuccillo; Stewart A Anderson
Journal:  Neurobiol Dis       Date:  2017-04-19       Impact factor: 5.996

5.  High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies.

Authors:  Fadi F Hamdan; Candace T Myers; Patrick Cossette; Philippe Lemay; Dan Spiegelman; Alexandre Dionne Laporte; Christina Nassif; Ousmane Diallo; Jean Monlong; Maxime Cadieux-Dion; Sylvia Dobrzeniecka; Caroline Meloche; Kyle Retterer; Megan T Cho; Jill A Rosenfeld; Weimin Bi; Christine Massicotte; Marguerite Miguet; Ledia Brunga; Brigid M Regan; Kelly Mo; Cory Tam; Amy Schneider; Georgie Hollingsworth; David R FitzPatrick; Alan Donaldson; Natalie Canham; Edward Blair; Bronwyn Kerr; Andrew E Fry; Rhys H Thomas; Joss Shelagh; Jane A Hurst; Helen Brittain; Moira Blyth; Robert Roger Lebel; Erica H Gerkes; Laura Davis-Keppen; Quinn Stein; Wendy K Chung; Sara J Dorison; Paul J Benke; Emily Fassi; Nicole Corsten-Janssen; Erik-Jan Kamsteeg; Frederic T Mau-Them; Ange-Line Bruel; Alain Verloes; Katrin Õunap; Monica H Wojcik; Dara V F Albert; Sunita Venkateswaran; Tyson Ware; Dean Jones; Yu-Chi Liu; Shekeeb S Mohammad; Peyman Bizargity; Carlos A Bacino; Vincenzo Leuzzi; Simone Martinelli; Bruno Dallapiccola; Marco Tartaglia; Lubov Blumkin; Klaas J Wierenga; Gabriela Purcarin; James J O'Byrne; Sylvia Stockler; Anna Lehman; Boris Keren; Marie-Christine Nougues; Cyril Mignot; Stéphane Auvin; Caroline Nava; Susan M Hiatt; Martina Bebin; Yunru Shao; Fernando Scaglia; Seema R Lalani; Richard E Frye; Imad T Jarjour; Stéphanie Jacques; Renee-Myriam Boucher; Emilie Riou; Myriam Srour; Lionel Carmant; Anne Lortie; Philippe Major; Paola Diadori; François Dubeau; Guy D'Anjou; Guillaume Bourque; Samuel F Berkovic; Lynette G Sadleir; Philippe M Campeau; Zoha Kibar; Ronald G Lafrenière; Simon L Girard; Saadet Mercimek-Mahmutoglu; Cyrus Boelman; Guy A Rouleau; Ingrid E Scheffer; Heather C Mefford; Danielle M Andrade; Elsa Rossignol; Berge A Minassian; Jacques L Michaud
Journal:  Am J Hum Genet       Date:  2017-11-02       Impact factor: 11.025

Review 6.  HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance.

Authors:  Yaya Wang; Diana Argiles-Castillo; Emma I Kane; Anning Zhou; Donald E Spratt
Journal:  J Cell Sci       Date:  2020-04-07       Impact factor: 5.285

7.  Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity.

Authors:  Bradley P Coe; Holly A F Stessman; Arvis Sulovari; Madeleine R Geisheker; Trygve E Bakken; Allison M Lake; Joseph D Dougherty; Ed S Lein; Fereydoun Hormozdiari; Raphael A Bernier; Evan E Eichler
Journal:  Nat Genet       Date:  2018-12-17       Impact factor: 38.330

8.  A de novo splice site mutation in EHMT1 resulting in Kleefstra syndrome with pharmacogenomics screening and behavior therapy for regressive behaviors.

Authors:  Amit Kumar Mitra; Jessica Dodge; Jody Van Ness; Israel Sokeye; Brian Van Ness
Journal:  Mol Genet Genomic Med       Date:  2016-12-26       Impact factor: 2.183

9.  Polygenic risk scores in schizophrenia with clinically significant copy number variants.

Authors:  Satoru Taniguchi; Kohei Ninomiya; Itaru Kushima; Takeo Saito; Ayu Shimasaki; Takaya Sakusabe; Yukihide Momozawa; Michiaki Kubo; Yoichiro Kamatani; Norio Ozaki; Masashi Ikeda; Nakao Iwata
Journal:  Psychiatry Clin Neurosci       Date:  2019-09-30       Impact factor: 5.188

10.  Calculating the statistical significance of rare variants causal for Mendelian and complex disorders.

Authors:  Aliz R Rao; Stanley F Nelson
Journal:  BMC Med Genomics       Date:  2018-06-13       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.